Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Eur J Neurol. 2015 Dec 14;23(3):527–541. doi: 10.1111/ene.12882

Table 2.

Multiple linear regressions showing the association between each spatio-temporal gait parameters* (dependent variable) and cognitive status (independent variable) adjusted on participant’s characteristics (n=1719)

MCI Dementia

Amnestic
β [95%CI] (P-value)
Non-amnestic
β [95%CI] (P-value)
Mild Moderate

AD
β [95%CI] (P-value)
Non-AD
β [95%CI] (P-value)
AD
β [95%CI] (P-value)
Non-AD
β [95%CI] (P-value)
Walking speed −4.70 [−8.65; −0.75] (0.020) −8.97 [−11.65; −6.29] (<0.001) −13.54 [−17.28; −9.79] (<0.001) −16.23 [−20.50; −11.96] (<0.001) −17.76 [−21.73; −13.79] (<0.001) −23.32 [−28.14; −18.50] (<0.001)
Stride length
 Mean value −3.19 [−6.66;0.28] (0.072) −7.65 [−10.00; −5.30] (<0.001) −11.16 [−14.45; −7.87] (<0.001) −14.85 [−18.56; −11.10] (<0.001) −17.09 [−20.56; −13.60] (<0.001) −22.88 [−27.11; −18.65] (<0.001)
 Cov 0.30 [−0.27;0.86] (0.301) 0.78 [0.40;1.16] (<0.001) 1.29 [0.76;1.82] (<0.001) 2.26 [1.65;1.87] (<0.001) 2.57 [2.01;3.14] (<0.001) 2.78 [2.09;3.46] (<0.001)
Stride time
 Mean value 0.03 [0.00;0.06] (0.050) 0.04 [0.02;0.06] (0.001) 0.06 [0.03;0.09] (<0.001) 0.06 [0.02;0.09] (0.001) 0.06 [0.02;0.09] (<0.001) 0.09 [0.05;0.013] (<0.001)
 Cov 0.43 [−0.11;0.96] (0.115) 0.83 [0.47;1.19] (<0.001) 1.06 [0.55;1.56] (<0.001) 1.31 [0.73;1.89] (<0.001) 1.75 [1.21;2.28] (<0.001) 2.07 [1.42;2.72] (<0.001)
Swing time
 Mean value 0.01 [−0.00;0.02] (0.112) 0.01 [−0.00;.0.01] (0.128) 0.01 [0.00;0.02] (0.007) 0.00 [−0.01;0.01] (0.586) 0.00 [−0.00;0.02] (0.977) 0.00 [−0.01;0.02] (0.559)
 Cov 0.40 [−0.78;1.57] (0.507) 0.089 [0.09;1.68] (0.028) 1.70 [0.59;2.81] (0.003) 1.43 [0.17;2.70] (0.027) 3.35 [2.17;4.52] (<0.001) 3.61 [2.18;50.4] (<0.001)
Stance time
 Mean value 0.02 [−0.00;0.05] (0.064) 0.03 [0.01;0.05] (<0.001) 0.04 [0.02;0.07] (<0.001) 0.06 [0.03;0.08] (<0.001) 0.06 [0.03;0.08] (<0.001) 0.09 [0.06;0.12] (<0.001)
 Cov 0.61 [0.03;1.20] (0.039) 1.08 [0.69;1.48] (<0.001) 0.97 [0.42;1.52] (0.001) 1.57 [0.94;2.20] (<0.001) 1.48 [0.89;2.06] (<0.001) 2.34 [1.63;3.05] (<0.001)
Single support time
 Mean value 0.01 [−0.00;0.02] (0.100) 0.01 [−0.00;0.01] (0.122) 0.01 [0.00;0.02] (0.007) 0.00 [−0.01;0.01] (0.579) 0.00 [−0.01;0.01] (0.873) 0.00 [−0.01;0.02] (0.480)
 Cov 0.33 [−0.82;1.49] (0.569) 0.87 [0.09;1.65] (0.029) 1.66 [0.56;2.75] (0.003) 1.38 [0.13;2.62] (0.030) 3.12 [1.97;4.28] (<0.001) 3.45 [20.5;4.86] (<0.001)
Double support time
 Mean value 0.02 [−0.01;0.04] (0.132) 0.03 [0.02;0.06] (<0.001) 0.04 [0.02;0.06] (<0.001) 0.05 [0.03;0.08] (<0.001) 0.06 [0.04;0.08] (<0.001) 0.09 [0.06;0.11] (<0.001)
 Cov 0.54 [−0.43;1.51] (0.276) 1.37 [0.71;2.02] (<0.001) 2.14 [1.22;30.6] (<0.001) 2.02 [0.98;3.07] (<0.001) 3.20 [2.22;4.17] (<0.001) 2.90 [1.72;4.08] (<0.001)
Stride width
 Mean value 0.12 [−0.54;0.78] (0.724) 0.35 [−0.10;0.80] (0.122) 0.13 [−0.49;0.76] (0.676) 1.36 [0.64;2.07] (<0.001) 1.02 [0.36;1.68] (0.003) 1.68 [0.88;2.49] (<0.001)
 Cov 0.64 [−2.43;3.72] (0.682) −0.72 [−2.81;1.37] (0.499) −0.90 [−3.82;2.01] (0.544) −4.10 [−7.42; −0.77] (0.016) −3.14 [−6.23; −0.05] (0.046) −5.32 [−9.08; −1.58] (0.005)
Stride velocity
 Mean value −4.54 [−8.53; −0.56] (0.025) −8.87 [−11.56; −6.16] (<0.001) −13.40 [−17.17; −9.62] (<0.001) −16.04 [−20.34; −11.73] (<0.001) −17.62 [−21.62; −13.62] (<0.001) −23.19 [−28.05; −18.33] (<0.001)
 Cov 0.73 [0.13;1.34] (0.018) 1.18 [0.77;1.59] (<0.001) 1.73 [1.16;2.31] (<0.001) 2.79 [2.14;3.45] (<0.001) 2.85 [2.25;3.46] (<0.001) 3.38 [2.64;4.12] (<0.001)

CHI cognitively healthy individuals; MCI: mild cognitive impairment; AD: Alzheimer’s disease; CoV: coefficient of variation; CI: confidence interval;

*

separated model for each gait parameter with each model adjusted on age, gender, number of drugs taken per day, body mass index, use of psychoactive drugs, depression symptoms and history of falls; β: coefficient of regression indicating a decrease or increase in value of gait parameter associated with cognitive decline, the reference group being cognitively healthy individuals; P-value significant (i.e., P < 0.05) indicated in bold.